July 2026
Navigate Questions About the Medicare GLP-1 Bridge Program
The Medicare GLP-1 Bridge launched July 1, 2026. This program allows eligible Medicare Part D patients to access certain GLP-1 medications for weight management for a $50 copay. Our articles explain which medications are included, which patients may qualify, and why prescriptions for indications such as type 2 diabetes, obstructive sleep apnea, or MASH should still be billed to Part D. We also outline how pharmacies should submit Bridge claims through CMS’s central processor, handle prior authorization, and counsel patients about copays, savings cards, and Part D cost-sharing limits. Your team can use our GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart to compare products and get guidance on switches.
Read More:
Community Pharmacies: Your Guide to Controlled Substance Rx Validation
Controlled Rx fraud is becoming harder to spot as fraudsters get even more creative. Our articles explain how to evaluate controlled prescription legitimacy using green flags and caution flags. We also outline how PDMP checks can help identify concerning patterns and what to do when federal, state, or pharmacy policies differ. Readers dive deeper into federal controlled Rx laws with our CE course Controlled Substance Prescription Validation.
Read More:
Hospitals: Know the Latest Guidance to Help Improve Stroke Outcomes
Hospital pharmacists should be ready to guide time-sensitive medication decisions for acute ischemic stroke. Our articles review when to use IV alteplase or tenecteplase, how to manage key risks such as recent DOAC use, and why add-on IV antithrombotics are not recommended to improve thrombolysis. We also outline practical monitoring steps, including BP and glucose targets, plus timing of antiplatelet therapy for secondary stroke prevention. For more guidance to optimize care, readers can access our Antiplatelets for Recurrent Ischemic Stroke chart and our Acute Ischemic Stroke Pharmacotherapy Checklist.
Read More:
Caffeine pouches deliver rapid, high doses of caffeine and are gaining popularity among teens and young adults, raising serious safety concerns. Our NatMed article breaks down how these products work and what to advise patients. Adults should stick to no more than 400 mg of caffeine daily, counting all sources. Kids and teens shouldn’t exceed 2.5 mg/kg daily – about 100 mg for the average 12-year-old – and should avoid these products altogether, especially given reports of pouches being distributed in schools.
Caffeine pouches deliver rapid, high doses of caffeine and are gaining popularity among teens and young adults, raising serious safety concerns. Our NatMed article breaks down how these products work and what to advise patients. Adults should stick to no more than 400 mg of caffeine daily, counting all sources. Kids and teens shouldn’t exceed 2.5 mg/kg daily – about 100 mg for the average 12-year-old – and should avoid these products altogether, especially given reports of pouches being distributed in schools.
In our latest episode, Atorvastatin Interactions: Foods and Supplements to Watch For, NatMed editors Jeff Langford, Andrea Stafford, and Kelly Daniels break down clinically relevant interactions using atorvastatin as a case study—and show how to apply a practical framework for identifying, interpreting, and managing these interactions at the point of care.
We're excited to share that we've launched a new Content Updates page on NatMed Pro that provides a real-time log of monographs recently reviewed and updated by our editorial team. Covering the past three months of updates, the page shows exactly which sections have changed—including Effectiveness, Safety, Adverse Effects, Drug Interactions, Dosing, and more—so you can quickly see what's new without digging through individual monographs.
Listen to this month’s podcast episode, Hypertension Treatment Updates, as our expert panel breaks down what every clinician needs to know about the 2025 hypertension guidelines. You’ll hear them discuss what’s changed, some controversies, and other practical takeaways to optimize blood pressure management for your patients.
All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Listen to the latest episode, Ivermectin, as our editors dig into what’s driving the buzz and what the evidence actually shows across a surprisingly wide range of uses. From viral misinformation to emerging global health research, they explore where ivermectin fits… and where it doesn’t.
All Rumor vs Truth podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Listen to our latest bonus episode, Navigating the Medicare GLP-1 Bridge: What Pharmacy Teams Need to Know, as our Associate Editor and Clinical Pharmacist Vickie Danaher breaks down the new Medicare GLP-1 Bridge program—what it is, how it works, and what pharmacy teams need to know right now.
All Clinical Capsules podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Decoding the Lipid Guidelines: What’s New, What’s Debated, and What to Do
Dates: July 21 & 23
In this month's live webinar, Decoding the 2026 Lipid Guidelines: What's New, What's Debated, and What to Do, you'll hear our panelists discuss significant updates to managing dyslipidemia, from lower LDL targets and earlier treatment to new testing recommendations. And you'll listen as our panelists debate whether the evidence supports the guideline's aggressive new stance on primary prevention, including the move to the PREVENT risk calculator, the expansion of coronary artery calcium (CAC) scoring, and the new push to measure lipoprotein(a) in every adult patient. Our panelists will also take a critical look at the real-world practicality of these recommendations for busy clinicians.
Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:
Upcoming 2026 Live Webinars
Check out our upcoming Pharmacy Essential live CE webinars.
Dates: July 14, 15, 18, 22, 30
Topics for July include:
*Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar.
GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Use our customizable chart to compare options and get guidance on switches.
Optimizing Care of Patients With Coronary Artery Disease
Post our checklist for a comprehensive guide to care.
Cholesterol Guidelines
Keep our chart on hand as a quick reference to managing cholesterol for primary or secondary prevention.
Artificial Intelligence in Pharmacy Practice
Review our resource for general AI concepts and guidance about potential uses in pharmacy practice.
Equianalgesic Dosing of Opioids for Pain Management
Post our chart to help guide these complex switches.
Pharmacy staff shortages and inconsistent technician training keep piling pressure on already strained systems. Expanding technician product verification offers a practical path forward—letting pharmacists practice at the top of their license by focusing on clinical care and patient services, while empowering technicians to take on greater responsibility. As more states authorize this practice, pharmacies that invest in structured verification training stand to gain a significant operational edge.
Now available through the Pharmacy Technician Learning & Practice Suite, the new Technician Product Verification (TPV) program helps you build that edge while meeting evolving state requirements. It tackles training hurdles head-on by turning everyday verification practice into accredited CE credit and a clear certification path. And if you already use the technician suite, you should already have access.
With TPV training, your pharmacy gains:
Most CE courses check a box. The TPV Training Program builds real-world verification skill.
We’re excited to have partnered with Becker’s Healthcare for this webinar featuring our Chief Pharmacy Officer, Dr. Tina Moen, PharmD, and Julie Lanza, CPhT-Adv, CSPT, CPTEd, FMSHP, Director of Pharmacy Education and Training at Beth Israel Lahey Health.
In this recorded session, Tina and Julie examine what leaders are missing about pharmacy workforce stability and why it increasingly shapes performance.
The conversation moves past staffing metrics to the operational and financial impact of turnover, the forces reshaping the pharmacy workforce, and the strategies organizations are using to build stronger, more sustainable teams.
Please note: This webinar is intended for educational and informational purposes only and does NOT offer CE/CME credit.
Join us at PTEC this weekend, July 9–11, or at NACDS next month. Meet with our experts, explore our pharmacy workforce solutions, and learn how leading organizations are improving compliance, workforce readiness, and patient care with TRC Healthcare.